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1. SUMMARY  
This annual progress report documents further advances in the devel-
opment and application of electrochemical etching of polycarbonate foils 
(ECEPF) for fast, intermediate, and thermal neutron dosimetry as well as 
alpha particle dosimetry. The fast (> 1.1 MeV) and thermal neutron dosi-
metry techniques were applied to a thorough investigation of the neutron 
contamination inherent in and about the primary x-ray beam of several 
medical therapy electron accelerators. Because of the small size of ECEPF 
dosimeters in comparison to other neutron meters, they have an unusually 
low perturbation of the radiation field under measurement. Due to this 
small size and the increased sensitivity of the ECEPF dosimeter over cur-
rent techniques of measuring neutrons in a high photon field, the fast 
neutron contamination in the primary x-ray beam of all the investigated 
accelerators was measured with precision and found to be greater than that 
suggested by the other, more common, neutron dosimetry methods. This fast 
neutron dose component ranged from 0.2% (neutron dose equivalent per x-
ray rad using RBE n = 10) for the Clinac-20, 18 MV x-ray beam, to t`a 1.3% of 
the x-ray dose in the BBC-45 betatron primary beam. We also found that 
fast neutron generation continued to increase between threshold and 45 MV 
rather trAan plateauing in the 20-25 MV region as other techniques have 
suggested. The thermal neutron dose measured by the ECEPF dosimeter was 
found to be approximately the same as that measured by other current 
techniques. During the course of our neutron investigations we also dis-
covered a heretofore unreported (in medical therapy accelerators) heavy 
charged particle fluence in the primary x-ray beams generated by > 25 MeV 
electron bombardment. This charged particle component is, in most cases, 
1 
15-20% of the fast neutron track density and has an average energy at the 
dosimeter (assuming certain conditions) of rt,/4 MeV in the 25 MeV betatron 
x-ray beam. Our data suggests this charged particle component may be due 
to deuterons liberated by (y,d) and (y,np) interactions in the high Z 
accelerator components touched by the primary beam. 
In a tangent field to the medical therapy accelerator research we have 
initiated an investigation into what may be a more important, albeit less 
controlable, area of photoneutron generation in high-energy x-ray therapy 
situations, viz. the human body as a neutron generator. Using a hetero-
geneous human phantom, our preliminary results at the bone-tissue 
interface show a fast neutron dose component which exceeds that found on 
the surface due to accelerator-produced photoneutron contamination. These 
fast neutron dose measurements range from n)1.5% (neutron dose-equivalent 
per x-ray rad) in the 25 MeV beam treatment volume to rN,, 4% of the x-ray 
dose in the 45 MeV betatron treatment volume. Many more tests are called 
for in this area with emphasis on the neutron dose at different tumor 
depths, bone-tissue interfaces, and measurements both inside and outside 
the primary beam treatment volume for different beam cross sections. 
Further advances were made concerning the phenomenon of two groups of 
tracks--one large and the other small--reported by Stillwagon (1978) (1) 
and questioned by Su (1979).
(2) 
The resolution of this question is ulti-
mately important to the health physicist because it concerns the mechanism 
of energy transfer or LET at the microscopic level. Our research has 
confirmed the existence of two distinct groupings of different diameter 
tracks. One set of tracks varies about a mean diameter of A) 50 microns 
and the other set about a mean diameter of nJ90 microns. Our experimental 
technique eliminated many of the scattering problems inherent, to varying 
2 
degrees, in both previous investigator's methods. 	These results were 
obtained using our standard electrochemical etching method consisting of 
an equal volume solution of 45% KOH and C 2H5OH and etching at 1000 V, 2kHz, 
at room temperature for ninety minutes. Further tests are being planned 
which will utilize our casting technique, described in this report, to 
incorporate different amounts of C and 0 molecules into the polycarbonate 
to help finally resolve questions of energy transfer mode. 
Our attempt to use the ECEPF dosimeter in conjunction with tablet 
radiators, albedo techniques and various filtering processes to measure 
the intermediate neutron energy dose has not been very satisfactory; i.e., 
while given improved results, it has not allowed us the accuracy we require 
in relation to known intermediate neutron fluences. In order to resolve 
this impass, our current direction of research in this area involves uti-
lizing our polycarbonate casting method to incorporate the radiator 
10 	i (either 
6 
 Li or 	B) nto the polymer. We are also investigating the use of 
plastics other than polycarbonate that, while not having some of the bene-
fits of polycarbonate, have lower energy thresholds for track formation 
and can thus be used in conjunction with the ECEPF to help measure dose in 
the entire neutron energy range. 
An adaptation of our thermal neutron dosimetry technique is being 
utilized to determine the 
10B content of blood examined after the injection 
of a 10B-loaded compound into the patient. This research is related to the 
Boron Neutron Capture Therapy (BNCT) procedure under investigation at the 
Georgia Tech Research Reactor. At present, a calibration curve of 10 B 
 concentration vs track density is being generated so that 
10
B concen ra-
tions in blood and tissue samples can be determined in future clinical 
trials. 
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EXPERIMENTAL RESULTS  
2.  INVESTIGATION OF HIGH-ENERGY MEDICAL THERAPY ACCELERATORS  
A primary tool in current cancer radiation therapy techniques is the 
high-energy x-ray beam generated in the betatron and linear accelerator. 
The bremsstrahlung x-rays from these medical accelerators are produced by 
impinging high-energy electrons upon metal targets. Fig. I gives a simpli-
fied illustration of the major components found in the primary beam of a 
typical accelerator. The components shown above the dashed line are found 
in the linac, and those located below the dashed line are common to both 
the linac and betatron. (3) These components are used either for the produc-
tion of x-rays or shaping of the x-ray beam cross-sectional profile and are 
typically made of such elements as lead, tungsten, platinum, aluminum, 
copper, or gold, usually in combinations. Table I shows the composition of 
the accelerator components evaluated in this research. 
At high x-ray energies ( > 6 MV) the threshold for photonuclear par-
ticle production is exceeded in most high Z elements as shown in Table II. 
Consequently, all of the components located in the primary beam shown in 
Fig. I must be considered as photoneutron, and to some extent charged 
particle generators. The dose delivered to the patient and operating 
personnel by the resultant particle fields, especially the neutron, is of 
concern to both the radiation therapist and the health physicist. 
The majority of photoneutrons produced by photons in the energy range 
between neutron production thresholds and ■,,/ 30 MeV are a result of the 
"giant photonuclear resonance" cross section. Fig. II illustrates an 
example of this cross section. For high Z materials the photon energy for 
4 





FIGURE-I SIMPLIFIED DIAGRAM ILLUSTRATING THE ACCELERATOR COMPONENTS EXPOSED TO THE PRIMARY BEAM. 
THOSE COMPONENTS LOCATED ABOVE THE DASHED LINE ARE FOUND IN TUE LINAC AND THOSE LOCATED 
BELOW THE DASHED LINE ARE COMMON TO BOTH THE LINAC AND BETATKuN.(3) 
TABLE I 
High Z Elements Found in Accelerators Investigated in this Research (3) 
ACCELERATOR ENERGY COLLIMATOR BEAM TARGET TARGET 
FILTER THICKNESS 
(mm) 
Allis-Chalmers 25 Pb Al Pt 1.6 
25 MeV Betatron 
Brown-Boveri 45 W & Pb Pb Pt 2.0 




High Z Elements Commonly Used in Accelerator 
ELEMENT 
Components and Some Parameters for Neutro ) 
Production by Giant Photonuclear Resonance 
ATOMIC 	ABUNDANCE 	(Y,n )THRESHOLD 	a max 
WEIGHT (%) 	ENERGY (MeV) (mb) 
ENERGY AT 
a max (MeV) 
Al 27 100.00 13.03 14 22.00 
Cu 63 69.17 10.84 70 16.00 
Cu 65 30.83 9.91 75 16.70 
Cu Nat. 9.91 70 17.00 
W 186 28.40 5.75 400 14.00 
W Nat. - 6.20 400 14.00 
Pt Nat. - 6.10 500 13.90 
Au 197 100.00 8.07 540 13.80 
Pb 206 25.10 8.12 514 13.59 
Pb 207 21.70 6.73 481 13.56 
Pb 208 52.30 7.38 491 13.46 







GIANT PHOTONUCLEAR RESONANCE 
10 	20 	30 	40 
	
50 
X-RAY E\ ERGY (mEv) 
FIGURE-II TYPICAL GIANT PHOTONUCLEAR RESONANCE CROSS-SECTION AS A FUNCTION OF END POINT 
BREMSSTRAHLUNG ENERGY 
the maximum giant resonance cross section is given approximately by 
k0= 80A L'3 MeV and varies between 13-18 MeV depending on the 
material.
(4) 	The maximum cross section, a max, is found from 3-6 MeV 
beyond the photoneutron production threshold and the peak full width at 
half maximum for heavy nuclei varies between 3-5 MeV. As can be seen in 
Fig. II, at higher photon energies beyond E max corresponding to a max 
(y, multiple n) interactions begin to predominate. The neutron energy 
spectra generated in the giant photonuclear resonance region results from 
neutrons produced by two distinct interaction processes: the "evaporation 
spectrum" and the "direct-emission spectrum".
(5) The relationship of this 
giant resonance production to other neutron generation cross sections is 
shown as a function of photon energy for lead, up to and including the 
photopion cross section, in Fig. III. Fig. IV illustrates a typical 
photoneutron energy spectrum generated when the high Z target Ta is bom-
barded with high energy electrons. The neutrons in the Maxwellian shaped 
portion of the curve are generated by being evaporated from the compound 
nucleus formed as the energy from the photon is transferred by its electric 
field to the nucleus; thus causing an oscillation induction where the 
protons as a group move oppositely to the neutrons as a group.
(6)  This 
distribution of neutron energies, which resembles a fission-spectrum and 
has an approximately isotropic angular distribution of emission, accounts 
for 85-90% of the photoneutrons found in the primary x-ray beam. The 
average energies of the neutron spectra range from ti 1.3 MeV for the 18 MV 
x-ray beam of the Clinac-20 to "'3 MeV for the BBC-45. As mentioned, this 
portion of the spectrum is adequately described by a Maxwellian distribu-
tion and can be given by:
(7) 
dN = En • exp(-En/T) 
dE 	2 
n T 
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Figure-III 	Qualitative Comparison of Neutron-Producing Mechanism - Cross-Sections as a 
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Figure-IV Accelerator Contamination Neutron Energy Spectrum Generated by Ta 
Target with Peak Bremsstrahlung Energies of 20 and 30 MeV, Compared 
to a Fission Spectrum. From NBS-97 (26) 
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where, T = the nuclear temperature (in units of MeV), characteristic of the 
target nucleus and its excitation energy. 	From this we see that the 




= 2T. (7) The remaining 10-15% of photoneutrons,responsible for 
the "bumps" in the spectral curve shown in Fig. IV, are found in the high-
energy tail attached to the fission-like spectrum. These neutrons are 
produced by the direct-emission or "photoionization" process in which a 
neutron (or n-p pair) in the nucleus receives all of an interacting pho-
ton's energy and is ejected at that energy minus the binding energy of the 
neutron to its nucleus. These directly emitter photoneutrons exhibit an 
angular distribution that is slightly peaked at 90 ° to the direction of the 
incident photon. Theoretically, this portion of the spectra could contain 
neutrons with an energy only a few MeV less than the end point maximum of 
the bremsstrahlung therapy beam. In practice, however, we do not expect 
any significant contribution from the neutrons above ^d20 MeV even in the 
45 MeV betatron beam. 
The dosimeter used in this study is based on electrochemical etching 
of particle tracks in low background (r■-, 2 tracks/cm
2 ) polycarbonate 
foils. The fast (> 1.1 MeV) neutron dose is a function of the number of 
recoil particle tracks produced primarily by recoil oxygen and carbon 
nuclei and alpha particles from (n,a) reactions with atomic constituents 
of the polycarbonate. The thermal neutron dose component is measured by 
. 
using specially designed 
6  LIT radiator tablets in conjunction with the 
polycarbonate foils and measuring the reaction particle track density as a 
result of alphas and tritons from the 
6  Li(n,a)
3H thermal neutron reaction. 
The charged particle dose is determined from the direct density of damage 
tracks formed in the polycarbonate. 
12 
As the recoil reaction or direct charged particle traverses the poly-
carbonate, damage regions are left behind around their trajectories. 
These regions are preferentially etched by the electrochemical etching 
sufficiently to be seen by the unaided eye and evaluated with low ( c 100x) 
magnification. The electrochemical etching of polycarbonate foil, ECEPF, 
dosimeter has been shown to have a dose-equivalent or rem response (as seen 
in Fig. V) over a wide neutron energy range once the threshold energy for 
track formation has been exceeded.
(1,2,23) 
In this study, multi-layer packets of 250-micron thick Transilwrap 
polycarbonate foil layers were exposed to 500-2000 rads of high-energy x-
rays, measured at the maximum dose point and typical TSD's, in the center 
of a 10 cm x 10 cm primary beam of a Varian Clinac-20 (18 MV x-ray beam), an 
Allis-Chalmers 25 MeV betatron and a Brown-Boveri 45 MeV betatron in both 
the 45 and 33 MV x-ray modes. The ECEPF dosimeter was irradiated in each 
accelerator beam with care taken to insure no significant neutron reflec-
tion was apparent from the treatment table, floor, etc. After exposure, 





OH and 45% KOH at 1000 V and 2 kHz for ninety minutes at 
room temperature. 
Charged Particle Measurement  
Fig. VI exhibits the polycarbonate dosimeter response as a function 
of the individual 250-micron thick foil layers in the multi-layer stacks 
exposed to the primary x-ray beam in each of the investigated accelerators. 
As can be seen, the response with increasing layer depth is relatively 
uniform with the 18 MV linear accelerator, suggesting only the fast neutron 
dose is being measured. Notice, however, the dosimeter repsonse in its 
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Figure-V Neutron Sensitivity (tracks/n) as a Function of Neutron Energy. Obtained by Sohrabi Using 
Electrochemically Etched 250 micron Polycarbonate Foils. These Data are Superimposed on 
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FIGURE-VI POLYCARBONATE FOIL RESPONSE AS A FUNCTION OF 250 MICRON LAYERS WHEN EXPOSED TO THE 
PRIMARY X-RAY BEAM OF SEVERAL MEDICAL THERAPY ACCELERATORS. 
pronounced effect in the initial layers in the 33 MV and 45 MV beams. Here 
the data exhibits a track density of, in some cases, 15-20% higher in the 
first layers before leveling off and remaining relatively stable through-
out successive layers (up to fourteen 250-micron thick layers were evalu-
ated in the BBC-45 MV studies). The results of a subsequent series of 
tests evaluating the effect of different thicknesses of thin (40 micron) 
polyethelene absorbers on this fluence can be seen in Fig. VII. 
If we assume this measured phenomenon is due to a charged particle 
component, the most likely candidates are protons, alphas, or deuterons. 
While we know that protons are liberated from the high Z nucleus in much 
the same fashion as neutrons (5) (although at lower fluences due to the more 
rigorous escape ordeal), tests to date have failed to show that the poly-
carbonate dosimeter can measure the proton track unless specially treated 
with U.V. light. (8) Both theoretical and experimental evaluations of the 
alpha particle generation in the energy range of medical therapy accel-
erators suggest that any alpha track densities (tracks/cm
2
) produced will 




During the high energy (> 25 MeV) direct-emission pro-
cess there is the possibility of not only measurable neutron and proton 
generation but also the possiblity of deuteron (or n-p pair) production. 
Since the separation energy for deuteron emission from the high Z nucleus 
is in most cases quite high (e.g., 15 MeV for Cu) and the penetrability of 
the Coulombic barrier quite rigorous, deuteron emission is often consid-
ered insignificant at the medical therapy beam energies in question. 
However, scant empirical measurements have suggested this deuteron compo-
nent to be in some cases as much as A/10% of the measured neutron fluence 
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Absorber Thickness (mg/cm2 ) 
Figure-VII Range Determination of Charged Particle Found in 25 MeV 
Betatron X-ray Beam. Track Density in Polycarbonate Foil 
as a Function of Absorber Thickness in Air (Calculated 
from Thin Polyethelene Absorbers). 
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(9,10,11) 
targets. 	 A possible explanation for this higher than predicted 
yield of photodeuterons is that the directly emitted photoneutron or 
photoproton may pick up another nucleon while escaping from the 
nucleus. (5) With this "pick-up" process in mind, statistical models have 




With the above in mind and comparing the range curves for alphas, 
protons and deuterons as illustrated in Fig. VIII with our experimental 
determinations of the range of the observed charged particle fluence from 
Fig. VII, we see that the most likely composition of this fluence incident 
on the dosimeter is 4 MeV deuterons. However, since no evidence has been 
uncovered that documents the ability of the ECEPF technique to measure 
deuterons, further testing utilizing "clean" deuteron beams of various 
energies is called for. 
Thermal Neutron Measurements  
Fig. IX shows a comparison between the thermal neutron dose measure-
ments made using the ECEPF dosimeter and one of the more prevalent tech-
niques currently used in medical therapy accelerators, indium foil activa-
tion using a water moderator. The figures are in thermal neutron dose per 
x-ray rad and exhibit relatively close agreement for both the 25 and 45 MeV 
betatron, considering the very small doses measured ( ry 11/2 mrem with the 
ECEPF dosimeter). 
Thermal neutron dose measurements were also conducted with the ECEPF 
technique at various locations inside the patient treatment room, at the 
operator console, and at other adjacent work areas during a typical patient 
treatment use of the 25 MeV accelerator at Emory University Winslip Clinic, 
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Figure-VIII Mean Range (mg/cm 2 ) in Air of Protons, Deuterons, and 
Alpha Particles as a Function of Energy. Adapted from 
Lapp and Andrews (31) and Morgan and Turner (32). 
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ACCELERATOR SLOW NEUTRON DOSE 
PER RAD X- RAY 
A-C 25 
IN +H20 MOD. 6LI-ECEOPF 
4.3 x 10 6 1.4x10-6 
BBC-45 2.9x10 6  1.4x 106  
FIGURE-IX THE ELECTROCHEMICAL ETCHING OF POLYCARBONATE FOIL (ECEPF) MEASUREMENT OF THE THERMAL 
NEUTRON DOSE EQIVALENT PER X-RAY (RAD) FOR TWO HIGH ENERGY MEDICAL ACCELERATORS, 
COMPARED TO THE MOST COMMON TECHNIQUE NOW IN USE FOR MEASUREMENT OF THERMAL NEUTRONS 































FIGURE-X THERMAL NEUTRON AREA DOSIMETRY OF THE 25 MEV ALLIS-CHALMERS TREATMENT ROOM AT EMORY 
UNIVERSITY WINSLIP CLINIC, ATLANTA GEORGIA. THE ECEPF+LiF THERMAL NEUTRON DOSIMETER 
WAS USED FOR THESE MEASUREMENTS. (These measurements were taken for a time =--20 min.) 
thermal neutron doses recorded at particular locations. 	As one would 
expect, a fairly uniform thermal neutron dose existed in the treatment room 
due to the thermalizing properties of the concrete floor and walls. The 
measurements at the operator console were negligible. 
Fast Neutron Measurements  
Fig. XI exhibits a comparison between the fast neutron dose equiva-
lent per x-ray rad determined by the ECEPF dosimeter and a cross section of 
other current methods of measuring fast neutron contamination in medical 
therapy x-ray beams. As can be seen the ECEPF technique suggests that the 
fast neutron dose is considerably larger than previous, less sensitive 
measurement techniques have exhibited. Fig. XII shows graphically a simi-
lar comparison to Fig. XI. Here we note that conventional methods of 
measuring the fast neutron contamination in x-ray beams exhibit a plateau, 
or at least considerably smaller values, in the 20-25 MV range; this would 
be consistant with expected fast neutron yields only if we were bombarding 
a thin (i.e., <1. radiation length thick) target with high-energy elec-
trons. This can be understood from Fig. XIII, which shows the increasing 
photoneutron generation as a function of increasing target thickness and 
of bombarding primary electron energy (which, of course, is directly 
related to the maximum x-ray energy). As the thickness of the target under 
electron bombardment increases to greater than one radiation length (X o 
in 
the graph) the photoneutron generation no longer plateaus around the 20-25 
MeV range, as it tends to do at one radiation length or less target 
thickness. Instead it continues to increase as the primary electron energy 
increases. As shown earlier in Fig. I, we must consider not only the 
target but all else in the primary x-ray beam as a photoneutron generator. 
The ECEPF dosimeter data suggests that if we consider the target, main 
22 
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AC-25 0,51 0.45 0.28 0.76 
BBC-33 1.04 
BBC-45 0.54 0.39 0.73 1.18 
( a) = N F - DOSE EQUIVALENT PER X-RAY DOSE - RAD 
FIGURE-XI THE FAST NEUTRON PERCENT DOSE EQUIVALENT PER X-RAY (RAD) AS MEASURED IN THE PRIMARY BEAM 
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FIGURE-XII GRAPHICAL COMPARISON OF FIG.-XI. THE ECEPF DOSIMETER RESPONSE TO FAST NEUTRONS IN 
THE PRIMARY BEAM OF SEVERAL HIGH ENERGY MEDICAL THERAPY ACCELERATORS, COMPARED TO 





































FIGURE-XIII NEUTRON YIELDS FROM ELECTRONS INCIDENT ON A LEAD TARGET OF 
VARIOUS THICKNESSES. ADAPTED FROM (4) 
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and our further testing has confirmed), we 
do indeed approach a "thick" target situation and find the photoneutron 
production to increase between threshold and 45 MeV rather than plateauing 
in the 20-25 MeV range as data from other less sensitive techniques have 
suggested. 
To determine the ECEPF dosimeter response to the photoneutrons gener-
ated by the various accelerator components (as illustrated in Fig. I) and 
at the same time determine the individual contribution of each component, 
the following test was performed. The dosimeter was exposed to 1000 rads 
of x-rays in the standard testing configuration (the same as our other fast 
neutron evaluations) except in each test one of the accelerator components 
was either physically removed from the primary beam (as with the flattening 
filter) or adjusted to give an indication of contribtuion (e.g., the lower 
collimation jaws were evaluated at a closed position, 10 x 10 cm, and 30 x 
30 cm while using a 10 x 10 cm dosimeter foil). From this data the main 
photoneutron generators in a typical patient treatment set-up were the 
target plus main collimator (78%) and the falttening filter (20%). This 
study was performed on the BBC-45 MeV betatron only, and the findings are 
consistant with those in the literature.(3 '7)  
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3. NEUTRON GENERATION IN A HETEROGENEOUS HUMAN PHANTOM 
The photoneutrons generated inside the human body during high-energy 
radiotherapy treatments differ significantly from those produced by the 
accelerator components. While the magnitude of accelerator produced 
photoneutrons is generally controlable (e.g., use of different Z mate-
rials, neutron shielding, etc.) the neutrons produced by high-energy 
photon interactions with the body are an unavoidable situation in accel-
erator radiotherapy. Also, unlike the accelerator produced neutrons which 
are predominantly found within the primary x-ray beam, the neutrons pro-
duced by the human body are found to varying extents, depending on the 
treatment field size, both inside and outside the treatment volume. Thus, 
for these reasons and since neutrons have a much different depth dose 
dropoff compared to x-rays as illustrated in Fig. XIV and Fig. XV, it is 
important that the medical physicist knows the extent and magnitude of 
these parameters for various treatment situations so that the optimum 
effective treatment plan can be formulated. 
Our research in this area utilizes a heterogeneous human phantom 
consisting of a 30 cm diameter x 45 cm high cylinder (0.5 cm thick poly-
ethelene wall) filled with Goodman's tissue-equivalent liquid (13) in which 
was placed a 4 cm diameter x 33 cm high cylinder (0.3 cm thick polyethelene 
wall) containing a bone-equivalent liquid.
(14) The elemental composition 
of these equivalents compared to those of reference man can be seen in 
Table III. Also shown in Table III are the thresholds for neutron genera-
tion and maximum cross sections for each element which appreciably 
contributes to the photoneutron fluence. In this study to date, neutron 
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Figure-XIV Absorbed Dose Per Unit Surface Dose (rad) as a Function 
of Depth in Water, Calculated for Different Photon Energies. 























0 	4 	8 	12 	16 	20 	24 	28 
Depth In Cylindrical Thorax Phantom of 30cm Diameter (cm) 
Figure-XV Calculated Dose Equivalent (rem) as a Function of Depth in 




Elemental Composition (% by weight) of Heterogeneous Phantom in this Research 
Compared to Reference Man (33),also a Listing of the Photoneutron Throlds 
and Maximum Cross Sections for the Major Contributing Elements' 41 




TISSUE EQUIVALENT 	PHOTONEUTRON 
LIQUID (13) 
THRESHOLD 	a max 
(MeV) (mb) 
H 7.0 10.2 6.5 10.2 
C 22.7 12.3 19.1 12.0 18.72 7 
N 3.9 3.5 3.9 3.6 10.55 15 
0 48.6 72.9 53.0 74,2 15.67 8 
Na 0.3 0.2 e,,, 	13 .-, 8 
Mg 0.1 0.2 e•-• 	16.5 ,-..,9 
P 7.0 6.8 ,..., 	13 21 
Ca 9.9 10.3 15.63 17 
S 0.2 - '''' 15 11 
Cl 0.1 - e"'" 	10.5 28 
K 0.2 - e, 13.5 24 
*S+K+P+ Na + Mg = 1.1% 
posterior to the primary x-ray beam, for a typical radiotherapy treatment 
set-up in the 25 MeV betatron beam and the 33 and 45 MV beam modes of the 
45 MeV betatron. Fig. XVI exhibits the neutron dose-equivalent per x-ray 
rad (as determined at the dosimeter depth) increase as a function of 
maximum x-ray energy of the primary beam. For this preliminary test, the 
treatment depth (to the bone--tissue interface) was 10 cm and the delivered 
x-ray dose was es, 1000 rad for each accelerator. As can be seen in Fig. 
XVI, the neutron dose increases appreciably between the 25 and 33 MV beams 
(1.5% to 3.21%) and then increases at a somewhat slower rate between the 33 
and 45 MV beams (3.2% to 4%). While the magnitude of neutron dose is hard 
to compare with theory (because of the wide variation depending on treat- 
ment set-up, depth dose, phantom composition, etc.), this is fairly 
consistent with the literature which predicts a large neutron fluence 
increase between 20 and 30 MeV with a more gradual increase above 30 
MeV. (15) 
Current tests are underway to evaluate the neutron dose at various 
depths in the phantom for tissue only and at all positions on the bone-
tissue interface. A myriad of tests are planned for this study in the 
future, some of which include the use of polymers with lower thresholds for 
track formation (e.g., CR-39) which will enable us to measure recoil pro-
tons from intermediate neutron energy interactions that may be of primary 
importance in the unwanted dose delivered outside the treatment area. 
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Anterior to x-ray beam 
/i/it 
/ Posterior to x-ray beam 
/ 4 
5.0 
25 	 35 	 45 
X-ray Maximum Energy (MeV) 
Figure-XVI Change in Neutron Dose Equivalent Per X-ray Dose (rad),from 
Neutrons Generated in a Heterogeneous Human Phantom as a 
Function of End Point Bremsstrahlung Energy. Taken at the 
Bone-Tissue Interface on Bone Surface Anterior and Posterior 
to Primary X-ray Beam. 
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4. TWO TRACK-DIAMETER PHENOMENON 
This study was initiated due to the somewhat different conclusions 
two of our previous investigators (Stillwagon and Su) arrived at as to 
whether the two track-diameter phenomenon exists or not and how the latent 
tracks are formed in the polycarbonate during alpha particle irradiation. 
Stillwagon (1978) (1) first reported that our ECEPF dosimeter was 
recording two distinct groupings of different diameter tracks during 




Am 9  and 
244
Cm alpha sources. These two 
sets of tracks varied about a mean diameter of 3.5-4.0 microns for the 
smaller and 10.0-10.5 microns for the larger as shown in the histogram of 
Fig. XVII. Stillwagon's data was generated using a source to dosimeter 
geometry configuration that was enclosed in a vacuum-sealed cylinder in 
which the air pressure could be varied to control the change in alpha 
particle energy (due to air absorption) incident on the polycarbonate 
dosimeter. The source to dosimeter distance was held constant but no 
collimation was used due to the weak alpha sources used. Consequently, 
this wide-angle geometry could have produced scatter tracks of various 
diameters at the detector surface. Stillwagon theorized that these two 
distinct groupings of tracks were caused (1) by alpha particles with ener-
gies near the Bragg peak (as shown in Fig. XVIII) accounting for the small 
diameter tracks and (2) recoil carbon and oxygen nuclei (from Rutherford 
scattering with high-energy alphas) accounting for the larger diameter 
tracks. 
In the studies reported by Su (1979)
(2) 
a 2.0 microcurie 
239
Pu source 
was used, but the alpha energy incident on the polycarbonate dosimeter was 
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Figure-XVII Relative Frequency of Track Diameters after Alpha Particle Exposure for a 
Polycarbonate Foil Etched One Hour at 800 V, 2 kHz, 24'C, in 45% KOH. 












Microns of Polycarbonate 
Figure-XVIII Efficiency of Track Production as a Function of Absorber 
Thickness,
3 
Polycarbonate Absorber Thickness Ns Calculated 
from g/cm , of Air. Count Rate was 1.6516 x 10//24 hours 
(from Stillwagon (1)) 
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source to dosimeter distance was collimated; however, the collimator con-
trol was somewhat questionable and by definition this arrangement assured 
a variation of angles at which the alpha particle strikes the foil as the 
energy distribution was changed with distance. Su's conclusion was, 
basically, that his research had failed to confirm the existence of the 
two-track phenomenon. He went on to explain the variation in track diame-
ter seen in his research and exhibited in the histogram of Fig. XIX as a 
function of the incident alpha energy and the depth in the polycarbonate 
foil at which the alpha reached its maximum, or Bragg peak, ionization 
point. 
Our research into this question has exhibited that two distinct 
groups of different diameter tracks do exist in the ECEPF dosimeter foil 
when used to record alpha particles with energies near the Bragg peak. The 
experimental apparatus used in this study consisted of a 
239Pu source (2.0 
microcurie) and dosimeter geometry held constant with a machined 0.5 inch 
ID collimator; this configuration was enclosed in a vacuum-sealed cylinder 
in which the air pressure could be varied. To insure that we would be 
irradiating with alphas near the Bragg peak using this geometry a track 
production efficiency vs alpha energy (or absorber thickness) curve was 
generated (see Fig. XX). An Ortec Surface barrier detector connected to a 
Model 8100 Canberra multichannel analyzer was used as the detector in the 
geometry described above to determine the total alpha counts and peak 
energies at various air densities. The Ortec detector was replaced by a 
250-micron thick polycarbonate foil in the same geometry position and 24-
hour irradiations were taken at the same air densities as used with the 
Ortec. From a comparision of the polycarbonate data with that of the 
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TRACK DIAMETER ( pa ) 
Figure-XIX Relative Track Diameter Distributions of 5.05 MeV Alpha Particles 
for Different Etching Times under the Standard Etching Conditions 
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5 	10 	15 	20 	25 	30 	35 
Effective Thickness of Polycarbonate (microns) 
Figure-XX Track Production Efficiency as a Function of Absorber Thickness. 
Polycarbonate Effective Thickness was Calculated from g/cm2 Air. 
Effective Attenuated Alpha Energy Determined by Bethe Curve (30) 
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equivalent polycarbonate thickness (calculated from the different air 
densities) was determined. From this curve an air density corresponding to 
a polycarbonate absorber thickness of ^J26 microns (and an incident alpha 
energy of P,./2.2 MeV) was chosen as the point of maximum efficiency. Five 
different 24-hour irradiation measurements were taken using 250-micron 
thick Trensilwrap polycarbonate foil dosimeters. The track diameters in 
each of the foils were measured using a light microscope with 430X magni-
fication and a Filar micrometer. The result of this investigation, as can 
be seen in Fig. XXI, clearly shows a frequency of smaller tracks varying 
about a mean diameter of —50 microns and a frequency of larger tracks 
varying about a mean diameter of ^390 microns. The difference in absolute 
track diameters in this research as compared to that of Stillwagon shown in 
Fig. XVII is due to the increased etch rate and track amplification found 




etched at 1000 V and 2 kHz for ninety minutes at room temperature. 
Thus, as stated previously, this research confirms the existence of 
the two track phenomenon. The next step in this matter is to determine why 
we are seeing the two track diameters. This is an important consideration 
since the linear energy transferred (and subsequent dose delivered) on a 
cellular level would be quite different for a 4 MeV carbon or oxygen recoil 
(the maximum energy transferred in Rutherford scattering with a 5.1 MeV 
alpha) as compared with an equivalent energy alpha linear energy transfer. 
With this type of energy transfer we could have a direct mechanism for 
chromosome breakage and irreparable damage could be caused in a DNA chain 
by the constituent atoms simply being knocked out of the chain. Of course, 
this damage mechanism would be going on in addition to the radial distribu-
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FIGURE-XXI 	DISTRIBUTION OF TRACK DIAMETERS FOUND IN A POLYCARBONATE FOIL AFTER IRRADIATION 
BY Pu-239 ALPHAS ATTENUATED TO 2.2 MEV THRU 26 MICRONS OF EFFECTIVE POLYCARBONATE 
AND ETCHED IN AN EQUAL VOLUME SOLUTION OF 45% KOH AND C 2 H 5OH AT 1000 V, 2 KHZ, AT 
ROOM TEMPERATURE FOR 90 MINUTES. 
Katz.(16 ')  Our current studies in this matter are concerned with adapting 
our polycarbonate casting method (as described later in this report) so as 
to incorporate various percentage amounts of carbon and oxygen molecules 
into the original C 16 11 140 3 . In this way we will be able to determine the 
effective importance of recoil nuclei from Rutherford type scattering when 
the dosimeter is exposed to alpha irradiation. 
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5. INTERMEDIATE ENERGY NEUTRON STUDIES 
The techniques employing electrochemical etching of polycarbonate 
foils for the measurement of fast and thermal neutron doses have been shown 
to be both accurate and reliable. Unfortunately, the intermediate neutron 
energy region is an extremely difficult one in which to evaluate absorbed 
dose to tissue; and as a result, such dosimetry in the past has been 
largely neglected. However, we feel this region of neutron energies is 
important in the field of health physics, especially in our studies of 
medical high voltage therapy x-ray sources operating at energies <15 MeV. 
Our research in this area of intermediate neutron energy so far has 
been only a continuation of our previous attempts utilizing thermal albedo 
techniques in conjuntion with 
6LiF and 10B thin-tablet radiators and poly-
carbonate foils. 
As we know, the human body is an efficient moderator of neutrons in 
that a flux of thermal neutrons is produced in and near the body surface 
when it is irradiated by a fast and intermediate neutron flux. At the 
point of measurement we must be concerned with two types of thermal albedo 
neutrons: (1) the component composed of both incident and reflected neu-
trons initially at thermal energies, the purely thermal albedo, and (2) the 
albedo component composed of the initially incident neutrons of interme-
diate and fast energies moderated and reflected by the body to thermal 
energies. (17) 
Utilizing a phantom consisting of a water-filled elliptical cylinder, 
20 cm x 30 cm in diameter and 40 cm high (holding X28 liters of water) and 
having 0. (18) 6 cm thick polyethelene walls, we constructed the d.: , .,.1L ,Rter 













0.08cm CADMIUM SHIELD 
POLYCARBONATE FOIL 	 
HELD IN PLACE WITH POLYETHYLENE TAPE 
Figure-XXII Albedo Neutron Dosimeter Arrangement for Measurement of the 
Intermediate Neutron Dose. 
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consisted of the following arrangement: (A) a bare polycarbonate foil (not 
shown), in the same plane, adjacent to but not in contact with the phantom 
(for fast neutron measurement); (B) a bare polycarbonate foil in contact 
with the phantom surface (fast and reflected fast neutron measurement); 
(C) an unshielded polycarbonate foil-tablet radiator sandwich, with the 
radiator in contact with the phantom (measuring, the incident fast and 
thermal and the albedo fast, thermal, and intermediate components); (D) a 
0.08 cm thick cadmium shield--polycarbonate foil--tablet radiator sandwich 
with the radiator side in contact with the phantom (measuring, the incident 
fast and albedo fast, thermal, and intermediate components). The maximum 
number oE interactions (due to both incident and albedo neutrons) which 
will form tracks in the polymer are shown in Fig. XXIII. From Fig. XXII we 
can see that the difference in track density behind "B" and "D" is due to 
thermal albedo neutrons from incident thermal, intermediate, and fast neu-
trons (i.e., (2), (5), and (6) in Fig. XXIII). Thus, the intermediate 
dose component can be determined by subtracting out the contributions of 
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F = thermal albedo factors for thermal, intermediate, and 
fast neutrons, respectively, (19) 
n = thermal neutron track registration efficiency,
(2) 
 (7.91 ± 0.82) x 10-4 ) 
K = fast neutron track registration efficiency, track/neut. 
d int 
	
	= conversion factor for intermediate neutrons
(20) 
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Figure-XXIII Reactions Which Produce Track Densities Behind "C" as shown in the 










= directional coefficiency of thermal and fast neutrons 
(incident direction to albedo direction) Sohrabi, 1975, 
(23) 
= fast albedo factor for fast neutrons (number of albedo 
fast neutrons/number of incident fast neutrons). 
A dosimeter system as described here was taped in place on the phantom 
surface and irradiated at the Health Physics Research Reactor, Oak Ridge 
National Laboratory. Three different runs were recorded as shown in Table 
IV with indications of the energy spectrum for no shield, steel shielded 
and lucite shielded irradiations. The individual polycarbonate foils were 
electrochemically etched in our standard solution and evaluated. As can be 
seen in Table V, the intermediate neutron dose-equivalents measured by 
this technique exhibit unacceptable deviation from the does-equivalent 
values calculated based upon the neutron spectra shown in Table IV and the 
dose-equivalent conversion factors in Fig. XXIV. 
While we will continue to consider the ECEPF dosi,.eter in conjunction 
with albedo techniques and various filtering methods, our current direc-
tion of research to hopefully solve the elusive intermediate neutron dose-
equivalent measurement problem involves the use of polymers other tha-
polycarbonate which may exhibit lower energy thresholds for t,l_ck forma-
tion. One of these, allyl diglycol carbonate, exhibits a reported proton 
energy range of track formation from <500 KeV to 1 MeV. (21)  Using a 
polymer such as this we can possibly take advantage of the dominant inter-
action found with intermediate energy neutrons (i.e., elastic recoils with 
hydrogen nuclei) using either a proton radiator foil with the polymer or 
perhaps the polymer alone. 
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TABLE IV 

















1 1.49 E7 1.22 E7 2.67 E4 3.77 E4 8.35 E4 
2 1.0 	E7 8.19 E6 3.31 E5 4.19 E4 9.32 E5 
3 6.7 E6 5.77 E6 9.81 E5 1.06 E6 1.11 E6 
4 4.97 E6 3.87 E6 4.03 E6 4.38 E6 6.65 E6 
5 3.01 E6 2.12 E6 1.05 E7 2.22 E7 1.43 E7 
6 1.5 	E6 1.16 E6 8.82 E6 3.38 E7 8.22 E6 
7 9.07 E5 6.08 E5 1.29 E7 9.36 E7 9.50 E6 
8 4.08 E5 2.13 	135 9.48 E6 1.40 E8 7.93 E6 
9 1.11 E5 9.80 E4 7.26 E5 5.95 E6 1.07 E6 
10 8.65 E4 7.64 E4 5.60 E5 8.11 E6 9.85 E5 
11 6.74 E4 5.95 E4 4.20 E5 3.94 E6 8.97 E5 
12 5.25 E4 4.63 E4 3.39 E5 3.49 E6 8.35 E5 
13 4.09 E4 3.61 E4 2.72 E5 1.57 E6 7.85 E5 
14 3.18 E4 2.81 E4 2.35 E5 1.85 E6 7.68 E5 
15 2.48 E4 2.19 E4 2.06 E5 6.99 E5 7. 11 E5 
16 1.93 E4 1.7 	E4 1.79 E5 2.82 E5 6.85 E5 
17 1.50 E4 1.03 E4 4.43 E5 3.18 E5 ., 	:6 E6 
18 7.10 E3 4.88 	133 3.90 E5 2.85 E5 J.87 E6 
19 3.35 E3 2.03 E3 4.54 E5 3.24 E6 2 45 E6 
20 1.23 E3 8.48 E2 2.92 E5 1.17 E6 1.79 E6 
21 5.83 E2 3.54 E2 3.47 E5 1.25 E6 2.38 E6 
22 2.14 E2 1.47 E2 2.37 E5 8.77 E5 2.30 E6 
23 1.01 	E2 6.96 El 2.18 E5 8.04 E5 1.78 E6 
24 4.79 El 3.73 El 1.32 E5 4.72 E5 1.18 #6 
25 2.90 El 2.26 El 1.28 E5 4.67 E5 1.19 E6 
26 1.76 El 1.37 	El 1.22 E5 4.50 E5 1.19 E6 
27 1.07 El 7.34 1.71 E5 5.89 E5 1.79 E6 
28 5.04 3.93 1.07 E5 3.58 E5 1.18 E6 
29 3.06 2.18 1.35 E5 4.78 E5 1.58 E6 
30 1.56 1.25 8.50 E4 3.13 E5 /.76 E5 
31 1.0 0.086 7.84 E4 2.56 E5 8.80 E5 
32 0.65 0.541 6.80 E4 2.19 E5 7.37 E5 
33 0.45 0.212 4.99 E5 1.58 E6 6.86 E6 
34 0.1 0.0224 9.41 E5 3.05 E6 5.02 E7 
5.0 E3 
(*) This number is the area of the histogram for each energy interval. 
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Figure-XXIV 	Conversion Factors for Neutrons. Unidirectional Broad Beam Normal Incidence. 





ECEPF/ALBEDO Measurement of the Intermediate Neutron Dose Equivalent 
for Different Shielded Runs of the Health Physics Research Reactor 
at ORNL, Compared to the Calculated Values of Dose Equivalent 
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6. BORON NEUTRON CAPTURE THERAPY (BNCT) 
The Boron Neutron Capture Therapy (BNCT) studies at the Georgia Tech 
Research Reactor are steadily progressing toward clinical trials. Though 
the therapy is potentially applicable against many types of tumors, cur-
rent emphasis is being directed toward the treatment of the malignant brain 
tumor, glioblastoma multiformae. This particular grade of LuAlor is 
characterized by a central necrotic tumor mass from which project numerous 
fingerlets into adjacent healthy brain tissue, making it particularly 
difficult to successfully treat with surgery or gamma radiation. 
BNCT has been proposed as an alternative therapy whereby a 
10
B-load .2.  
compound injected into the patient is preferentially taken up by the tumor, 
but is prevented from infiltrating the healthy brain tissue b .-  the blood 
brain barrier. The head is then irradiated with an epithermal neutron 
beam, wh -ich is thermalized by the time it reaches the tumor. The 
i particles produced from the 
10
B(n, a)
7  Li interaction within the tumor thu s 
irradiates the cancerous tissue in a very localized manner, ._eeping the 
uc.,e to the surrounding healthy tissue to a minimum. 
An epithermal beam port has been designed and constructed over the 
past year and is in place at the Georgia Tech Research Reactor (GTRR). The 
beam remains to be characterized as to its Y-contamination as well as its 
neutron energy spectrum. Our developments in the fast and thermal capa-
bilities of the ECEPF dosimeter are presently being used to help in tais 
task. At the same time a biological dosimeter is being developed to 
determine the RBE of the combined radiations in the beam. 
At present, polycarbonate foils are being used 	calibrate a system 
i to determine the level of 10B in the patient's blood at the time of 
50 
epithermal neutron irradiation so that the neutron fluence for effective 
therapy can be determined. Small polycarbonate are placed in plastic 
vials containing various concentrations of boric acid. The vials are then 
irradiated at a thermal neutron port with a known fluence, etched, and 
inspected for alpha tracks from the 10B(n, a)
7 
 Li reaction. From this data, 
a calibration curve of 
10
B concentration vs track density will be gener-
ated, from which 10B blood levels can be determined during future clinical 
trials. 
A more complex problem is to determine the 
10
B distribution in the 
tumor mass. Studies must be conducted on test animals to determine where 
and to what degree the compound concentrates, as well as the uniformity of 
the distribution within the central tumor mass as compared to the finger- 
10 lets. Our group currently has a sample of the most promising B compound 
which will be injected into rats and beagles with induced tumors. The 
animals will then be sacrified and tissue sections from the tumors will be 
placed on sections of polycarbonate foils and irradiated at the thermal 
neutron port. The etched foils' reaction alpha tracks will serve as 
indicators of the 
10
B. 
Studies are also underway to evaluate the depth dose of fast, inter-
mediate, and thermal neutrons in several tissue-equivalent phantoms to 
determine the actual neutron fluence as well as contributions present 
various distances into the brain. 
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7. Thermal Neutron Dosimetry  
The 
6 
 LiF radiator tablet--polycarbonate foil--thermal neutron dosi-
meter developed earlier in our research has provided an extremely sensi-
tive and reliable method to measure the thermal neutron dose-equivalent. 
. 
Unfortunately, the use of 
6  LIF (or 
10 B) tablet radiators has several 
inherent problems; namely, the hydroscopicity and fragility of the thin 
tablets and the poor spatial response of the dosimeter configuration. To 
help eliminate these unwanted characteristics and at the same time keep the 
desirable aspects of the dosimeter (i.e., sensitivity < 1 mrem) we are 
perfecting a polycarbonate casting method which will allow us to incor-
porate the charged particle radiator compound into the foil itself. Our 
procedure for this technique is as follows. 
A smooth pane of plate glass (30 cm x 30 cm) is cleaned with toluene 
and coated with a thin uniform film of glycerin (we use a dip bath of 
dissolved cherry jell-o). The glycerin coat is allowed to dry. A section 
of standard 250-micron thick polycarbonate is dissolved in a suitable 
solvent (e.g., toluene or acetone) under a laboratory hood. The desired 
"loading solution" is then mixed with the dissolved polycarbonate. In 
order to achieve a uniform distribution of "loadant", the compound should 
be soluble in the same solvent as the polycarbonate. A puddle of the 
loaded polycarbonate solution is placed on the glycerin-coated glass plate 
and spread to the desired uniform thickness by using a "doctor blade". The 
glass plate and polycarbonate film coating is covered, to protect from dust 
collection, and allowed to dry. We then cut the dry "loaded" polycarbonate 
film into the desired dosimeter sizes, immerse the entire plate in a warm 
water bath and the individual sections of polycarbonate float to the water 
surface as the glycerin layer dissolves. 
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Perfecting our casting and loading technique has, necessarily, been a 
learning process. However, we are progressing steadily towards our ini-
tial thermal irradiation evaluations. This technique affords our reserach 
much freedom (from suppliers minimum order requirements) and is applicable 
to questions involved in several areas of our research; such as, thermal 
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In 1956, he was the first president of the Health Physics Society, and 
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gold medals for meritorious work in the field of radiation protection by 
the Royal Academy of Science of Sweden. 
Dr. Morgan received the Distinguished Alumni Award and the honorary 
Doctor of Science Degree from Lenoir Rhyne College, honorary membership in 
Sigma Pi Sigma from Berea College, and the First Distinguished Service 
Award of the Western Chapter of the Health Physics Society. He is a member 
of the Health Physics Society, the International Radiation Protection 
Association, the American Public Health Association, the American Associa-
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these over the past few years is as follows: 
"Common Sources of Human Exposure to Ionizing Radiation in the United 
States," American Engineer, July 1968. 
"Ionizing Radiation: Benefits Versus Risks," Annual Meeting of the 
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published in Health Physics, Vol. 17, No. 4. 
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Commission on Radiological Protection," Sixth Annual Meeting of the 
Gesel.lschaft fur Nuclearmedizin, Wiesbaden, Germany, September 26-
28, 1968; published in Proceedings, 1969. 
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First European Congress of the International Radiaton Protection 
Association, Menton, France, October 9-11, 1968; Published in 
Proceedings, 1968. 
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International Congress of Radiaton Protection, Rome, Italy, Vol. 1, 
3, Pergamon Press, 1968. 
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Radiation to Medical and Dental Patients," Seminar sponsored by the 
National Center for Radiological Health, Rockville, Maryland, 
November 15, 1968, Seminar Paper 003. 
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Uranium Mines of the United States," Hearing on Radiation Standards 
for Mines, Washington, D.C., November 20, 1968; Congressional Record, 
1968. 
"Supplemental Statement on the Proper Working Level of Radon and Its 
Daughter Products in the Uranium Mines of the USA," Supplement to 
Testimony presented on November 20, 1968, Washington, D.C.; 
Congressional Record, 1968. 
"Future Opportunities in Health Physics," Health Physics Society 
Midyear Topical Symposium, Los Angeles, California, January 29-31, 
1969. 
"Risks from Diagnostic X-Rays," Yale Scientific, Vol. XLII, No. 5, 
February, 1969; Reprinted from Yale Scientific in the Journal of the  
American Radiography Technologists, Vol. XIV, No. 4, Winter 1969. 
"Radiation Standards for Reactor Siting," Testimony presented before 
the Joint Committee on Atomic Energy at its Hearings on Environmental 
Effects of Producing Electrical Power, Phase 2, January 1970; 
Congressional Record. 
"Energy Pollution of the Environment," Midyear Symposium of the Health 
Physics Society, Louisville, Kentucky, January 28, 1970; Proceedings 
published in USPHS-BRH Series, BRH/DEP-70-26, Oct., 1970. 
"A Time of Challenge to the Health Physicist," Presidential Address 
presented before the Second International Congress on Radiaton 
Protection, May 8, 1970, Brighton, England; Health Physics, Vol. 20, 
May, 1971, pp. 491-498. 
"Standards for the Control of Effluents," published in Environmental 
Aspects of Nuclear Stations, IAEA, Vienna, 1971 
"My Opinion--You Can Drastically Cut X-Ray Exposure Below Today's 
Levels," Consultant, March/April, 1970. 
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"Exposure in the United States," and "Mogliche Folgen einer 
Ubermassigen Medizinischen Strahlenbelastung in der Vereinigten 
Staaten von Amerika," Rontgen-Blatter, 27, 127 (March 1974). 
"Reducing Medical Exposure to Ionizing Radiation," American Industrial 
Hygiene Journal (May 1975). 
Two chapters in text, Environmental Problems in Medicine titled 
"Exposure to Non-Ionizing Radiation" and "Ionizing Radiation 
Exposure," W. D. McKee, Editor; Chas. C. Thomas Publisher, 1974. 
"Types of Environmental Health Physics Data That Should be Collected 
and Evaluated in a Nuclear Power Program," in Environmental Impact  
Statements for Nuclear Power Plants, 1975, Pergamon Press, Chapters 
by K. Z. Morgan in test, Environmental Impact of Nuclear Power  
Plants, by R. A. Karam and K. Z. Morgan, GEORGIA INSTITUTE OF 
TECHNOLOGY SERIES IN NUCLEAR ENGINEERING, Pergamon Press 1975. 
"The Bases for Standards and Regulations" in Environmental Impact  
Statements for Nuclear Power  Plants, 1975 Pergamon Press, Chapters 
by K. Z. Morgan in text, Environmental Impact of Nuclear Power  
Plants, by R. A. Karam and K. Z. Morgan, GEORGIA INSTITUTE OF 
TECHNOLOGY SERIES IN NUCLEAR ENGINEERING, Pergamon Press 1975. 
"Release of Radioactive Materials from Reactors" and "Ways of 
Reducing Radiation Exposure in a Future Nuclear Power Economy," 
in Nuclear Power Safety, GEORGIA INSTITUTE OF TECHNOLOGY IN NUCLEAR 
ENERGY, Pergamon Press. 
"Transportation of Radioactive Material by Passenger Aircraft," Report 
to Joint Committee of Congress on Atomic Energy, Report No. 1 -
Sept. 17, 1974, U.S. Government Printing Office. 
"Health Physics - Past, Present, and Future," presented at First Asian 
Regional Congress of the International Radiation Protection Assn. in 
Bombay, India, Dec. 1974; published in Proceedings. 
"Suggested Reduction of Permissible Exposure to Plutonium and Other 
Transuranium Elements," J. Am. Ind. Hygiene 36, (8), 567 (Aug. 1975). 
"Effects of Radiation on Man - Now and in the Future," in Energy and  
the Environment -- Cost-Benefit Analysis; Pergamon Press, 1976, 
Chapters by K. Z. Morgan in text, Energy and the Environment, Cost  
Benefit Analysis, by R. A. Karam and K. Z. Morgan, GEORGIA INSTITUTE 
OF TECHNOLOGY SERIES IN NUCLEAR ENGINEERING, Pergamon Press 1976. 
"Programs Needed for Education and Training of Health Physicists," 
Proc. Am. Phys. Soc. Meeting, December 1974. 
"Recent Developments in Fast Neutron Personnel Dosimetry Using Track 
Etch Methods," presented at Congress of the International Radiation 
Protection Assn., Holland, May 1975; published in Proceedings. 
"Medical Radiation Protection," presented at Health Physics 
Meeting, Buffalo, New York, July 15, 1975. 
"Ways of Reducing Exposure in a Future Nuclear Power Economy," presented 
at American Public Health Association Annual Meeting, Chicago, 
Illinois, November 18, 1975. 
"A Course on Non-Ionizing Radiation Protection for State and Local 
Health Officers," Proceedings of Health Physics Society, Denver, 
Colorado, February, 1976. 
"The Particle Problem," Third International Summer School on Radiation 
Protection, Herceg Novi, Yugoslavia, published in Boris Kidric 
Institute Series, August-September 1976. 
"The Linear vs. The Threshold Hypothesis," Third International Summer 
School on Radiation Protection, Herceg Novi, Yugoslavia, published 
in Boris Kidric Institute Series, August-September, 1976. 
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"History of the Health Physics Society," published as part of the RSNA  
Symposium on the Critical History of American Radiology (Nov. 1970) 
"Standard Man-Standard Patient," Medical Radioisotopes: Radiation Dose 
and Effects, AEC Series 20, p. 87, June 1970. 
"History of the International Radiation Protection Association," 
published in Proceedings of the RSNA Symposium on the Critical History  
American Radiology, November 1970. 
"Criteria for the Control of Radioactive Effluents," IAEA Symposium 
on Environmental Aspects of Nuclear Power Stations, UN Building, 
New York, August 1970, Proceedings published, this paper is IAEA-
SM-146/10; synopsis published also in Environmental Studies, 1971. 
"Maximum Permissible Levels of Exposure to Ionizing Radiation," 
International Summer School on Radiation Protection, Boris Kidric 
Institute of Nuclear Sciences, Cavtat, Yugoslavia, September 20-30, 
1970; Proceedings published in 1971 under title of "Radiation 
Dosimetry." 
"President's Report on the General Assembly of IRPA," Brighton, England, 
May 1970, Health Physics, Vol. 20, No. 5, 1971. 
"History of Radiation Protection," Symposium Commemorating the 75th 
Anniversary of the Discovery of X-Rays, Milwaukee, November 13-14, 
1970; Materials Evaluation, Vol. XXIX, No. 3, March 1971. 
"Why the 1968 Act for Radiation Control for Health and Safety Is 
Required," Radiology, Vol. 99, No. 3, pp. 569-588, June 1971. 
"Excessive Medical Diagnostic Exposure," Third Annual National Conf. 
on Radiation Control, Scottsdale, Arizona, May 3, 1971; published in 
Proceedings. 
"Health Physics and the Environment," International Symposium on Rapid 
Methods for Measurement of Radioactivity in the Environment, 
Neuherberg, Federal Republic of Germany, IAEA-STI/PUB/289, Vienna, 
1971. 
"Adequacy of Present Radiation Standards," presented at the Environmental 
and Ecological Forum, Silver Spring, Maryland, January 20, 1971; 
Proceedings of Forum published in 1972, USAEC-TIC-25857. 
"Proper Use of Information on Organ and Body Burdens of Radioactive 
Material," presented at the IAEA/WHO Symposium on the Assessment of 
Radioactive Organ and Body Burdens, Stockholm, Sweden, November 22-
26, 1971, IAEA/SM/150-50; Proceedings of Symposium published by IAEA. 
"Health Physics Measures to Implement New USAEC Regulations Relating to 
Radiation Exposure of the General Public," Budapest, May 1971; 
Proceedings published by Akademiai Kiado, Budapest, Hungary. 
"The Need to Reduce Medical Exposure in the United States," outline of 
testimony presented before the Health and Welfare Subcommittee of 
the Senate Committee on Labor and Public Welfare on Senate Bill 
S.3327, May 15, 1972, Washington, D.C.; published in Congressional 
Record, 1972. 
"Comparison of Radiation Exposure of the Population from Medical 
Diagnosis and the Nuclear Energy Industry," Transactions ANS, 15:1, 
64 (June 1972). 
"Environmental Impact of Natural and Man-Made Ionizing and Non-Ionizing 
Radiations," Second International Summer School on Radiation Protec-
tion, Herceg Novi, Yugoslavia, Aug. 1973; Proceedings, 1973. 
"The Need for Radiation Protection," Radiologic Technology, 44, 6, 
p. 385 (1973). 
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"Current Problems and concepts of the Health Physicist," Third 
International Summer School on Radiation Protection, Herceg Novi, 
Yugoslavia, published in Boris Kidric Institute Series, August-
September 1976. 
"Use of Recycle Plutonium in Mixed Oxide Fuel in Light Water Cooled 
Reactors," testimony presented at public hearings on MOX fuel, 
Washington, D.C., Nov. 1976. 
"Keeping Dose Commitments ALAP," Proc. ANS National Topical Meeting, 
71, Tucson, Arizona, October 6-8, 1975. 
"Radiation-Induced Health Effects," Science 195, 157, 344 (January 28, 
1977). 
"The Dilemma of Present Nuclear Power Programs," Proc. of Hearings  
Before the Energy Resources Conservation and Development Comm., 
Sacramento, Cal., February 1, 1977. 
"Comments on Operation of the Kerr-McGee Cimarron Facility and the 
Karen Silkwood Case," before the Congressional Small Business Comm., 
April 26, 1976. 
"Data Interpretation," Proceedings of Workshop on the Utilization and  
Interpretation of Environmental Radiation Data, Orlando, Fla., 
March 1-3, 1976. 
"Rolf M. Sievert: The Pioneer in the Field of Radiation Protection," 
Health Phys. 31, 263-264 Sept. 1976. 
"Health Hazards from Diagnostic and Therapeutic X-Ray," Proceedings of 
Conference on Diagnostic Imaging, Chicago, Ill., Sept. 27, 1976. 
"Yes is the Answer to Question of R. H. Thomas and D. D. Busick, 'Is 
It Really Necessary to Reduce Patient Exposure?"' J. Am. Ind.  
Hygiene 37, 665-667, Nov. 1976. 
"The Linear Hypothesis of Radiation Damage Appears to Be Non-Conservative 
in Many Cases," Proceedings of Fourth International Congress of the  
International Radiation Protection Association, Paris, France, April 
25-29, 1977. 
"Possible Consequences of Excessive Medical Exposure in the United 
States," Given before the Fachverband fur Strahlenschutz at the Bern, 
Switzerland, meeting, March 21, 1973 and published in the Fachverband 
Proceedings of, 1973. 
"Biological Effects of Ionizing Radiation," published in Proceedings of 
Short Course, September 9, 1974. 
"Appropriateness of Regulations for Air Shipment of Radioactive 
Materials," Miami Beach, Florida, September 23, 1974, International 
Conference on Shipping of Radioactive Material; and published in 
Proceedings, 1975 
"Recent Developments in Fast Neutron Personnel Dosimetry Using Track Etch 
Methods," Proc. 3rd European Congress IRPA, Paper 14, Amsterdam, The 
Netherlands, May, 1975, with Mehdi Sohrabi 
"What is the Misunderstanding All About?" Bulletin of Atomic Scientists  
57, 56-58 (February 1979). 
"Neutron Dosimetry in High Energy X-Ray Beams of Medical Accelerator," 
Phys. Med. Biol. 24, No. 4,756 (1979), M. Sohrabi and K. Z. Morgan. 
"Alpha Particle Track Production in Polycarbonate Foils Amplified by 
Electrochemical Etching," Nucl. Tracks 3, 185 (1980), G. B. Stillwagon 
and K. Z. Morgan. 
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"Energy Dependence of Fast Neutron Dosimetry Using Electrochemical 
Etching, "Trans. Am. Nucl. Soc. Student Conference, Gainesville, 
Fla., 1978, S. J. Su and K. Z. Morgan. 
"Should Permissible Limits for Occupational Exposure be Reduced?" Proc. 
of Annual Meeting of the Health Physics Soc., Minneapolis, Minn., 
June 19, 1978. Published in proceedings of Fourth International Summer 
School on Radiation Protection, Boris Kendric Institute, Belgrade, 
Yug., Sept., 1979. 
"A New Polycarbonate Fast Neutron Personnel Dosimeter," Amer. Ind. Hygiene 
Assn.  J. 39, 438-447 (June 1978) K. Z. Morgan and M. Sohrabi. 
"Purpose of Radiation Protection Monitoring," IAEA Symposium on Advances 
in Radiation Protection Monitoring, Stockholm, Sweden, IAEA SM-226/139, 
pp. 3•20, June 26-30, 1978. 
"Should Radiation Exposure from Operation of Nuclear Power Plants be 
Reduced?"Bossey, Switzerland, Pub. Bulletin of the World Council of  
Churches, May 2-7, 1978. 
"Cancer and Low-Level Ionizing Radiation," The Bulletin of Atomic Scien 
tists, 30-41, (September 1978). 
"The Effect of Field Strength and Frequency in the Electrochemical Etching 
of Recoil Particle Tracks in Polycarbonate," Health Physics 35, 894 
(Dec. 1978), M. Sohrabi and K. Z. Morgan. 
"Risk of Cancer from Low Exposure to Ionizing Radiation," Symp. of the 
AAAS, Washington, D. C., February 17, 1878. 
"Are the Current Standards and Guidelines for Low -Level Radiation Adequate 
to Protect Public Health?" "What are the Current Standards?", Comments 
made by KZM acting as moderator in Senate Conference, Washington, D.C., 
Senate Office Bldg., February 10, 1978.. Published in Congressional 
Record and Reprinted by the Environmental Policy Institute. 
"Significance of Human Exposure to Low-Level Radiation," Presented before 
Congressional Hearing, Washington, D. C., January 24, 1978, published 
in Congressional Record. 
"Walter S. Snyder," Health Physics 34, 1-2 (January 1978). 
"A Chirper Checker - Adjunct to the Use of Personal Radiation Monitors," 
Health Physics 35, 693-697 (November 1978), P. S. Stansbury and 
"Evaluating the Bulk Etching Rate for Polycarbonate Foils During Electro- 
chemical Etching," Health Physics 34, 735 (1978), G. B. Stillwagon, 
K. Z. Morgan, and S. J. Su. 
"How Dangerous is Low Level Radiation," New Scientist, April 5, 1979. 
"Two Sizes of Alpha Tracks in Polycarbonate Foils," Health Physics 36, 741, 
G. B. Stillwagon and K. Z. Morgan. 
"Decommissioning of the Gorleben Facility," published in Gorleb 	Proceed  
ings, 1979. 
"The Non--Threshold Dose/Effect Relationship," published in Sym. 	Proceed  
ings of Nat. Academy Sc., Sept. 27, 1979. 
"Radiation-Induced Cancer in Man," presented to . Senate Subcommittee on 
Energy, Nuclear Proliferation and Fed. Services, Sen. John Glenn, 
Chairman, March 6, 1979. 
"Education and Training of Health Physicists," Proc. of Midyear Sym. of 
Health Phys. Soc., Honolulu, Hawaii, Oct., 1979. 
"Hazards of Low-Level Radiation," 216-289, 1980 Ed. of Encyclopaedia 
Britannica. 
"Appreciation of Risks of Low-Level Radiation vs. Nuclear Energy," pub. in 
Comments on Molecular and Cellular Biophysics, 1980. 
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